267 related articles for article (PubMed ID: 11122108)
21. Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients.
Roth MD; Gitlitz BJ; Kiertscher SM; Park AN; Mendenhall M; Moldawer N; Figlin RA
Cancer Res; 2000 Apr; 60(7):1934-41. PubMed ID: 10766183
[TBL] [Abstract][Full Text] [Related]
22. Generation of dendritic cells from leukaemia cells of a patient with acute promyelocytic leukaemia by culture with GM-CSF, IL-4 and TNF-alpha.
Narita M; Takahashi M; Liu A; Ayres F; Satoh N; Abe T; Nikkuni K; Furukawa T; Toba K; Aizawa Y
Acta Haematol; 2001; 106(3):89-94. PubMed ID: 11713372
[TBL] [Abstract][Full Text] [Related]
23. Immunostimulatory properties of human dendritic cells generated using IFN-beta associated either with IL-3 or GM-CSF.
Mazouz N; Detournay O; Buelens C; Renneson J; Trakatelli M; Lambermont M; Goldman M; Toungouz M
Cancer Immunol Immunother; 2005 Oct; 54(10):1010-7. PubMed ID: 15864589
[TBL] [Abstract][Full Text] [Related]
24. Production of granulocyte-macrophage colony-stimulating factor by T cells is regulated by B7 and IL-1 beta.
Kruger M; Van Gool S; Peng XH; Coorevits L; Casteels-Van Daele M; Ceuppens JL
Immunology; 1996 May; 88(1):49-54. PubMed ID: 8707349
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic and functional characterization of the host immune compartment of chronic myeloid leukaemia patients in complete haematological remission.
Guarini A; Breccia M; Montefusco E; Petti MC; Zepparoni A; Vitale A; Foa R
Br J Haematol; 2001 Apr; 113(1):136-42. PubMed ID: 11328293
[TBL] [Abstract][Full Text] [Related]
26. The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells.
Pogue SL; Preston BT; Stalder J; Bebbington CR; Cardarelli PM
J Interferon Cytokine Res; 2004 Feb; 24(2):131-9. PubMed ID: 14980077
[TBL] [Abstract][Full Text] [Related]
27. Recognition of chronic myelogenous leukaemia cells by autologous T lymphocytes primed in vitro against the patient's dendritic cells.
Müller L; Provenzani C; Faul C; Pawelec G
Br J Haematol; 2001 Mar; 112(3):740-8. PubMed ID: 11260079
[TBL] [Abstract][Full Text] [Related]
28. In vitro inducing effect of dendritic cells cotransfected with survivin and granulocyte-macrophage colony-stimulating factor on cytotoxic T cell to kill leukemic cells.
Zhu XP; Chen ZZ; Li CT; Lin X; Zhuang JL; Hu JD; Yang T; Xu ZS
Chin Med J (Engl); 2008 Nov; 121(21):2180-4. PubMed ID: 19080181
[TBL] [Abstract][Full Text] [Related]
29. [Influence of IFN-alpha and IFN-alpha combined with GM-CSF on expression of the genes related to cell apoptosis of MNCs from bone marrow in CML patients].
Tang LJ; Chen HC; Peng XH
Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):570-2. PubMed ID: 12516408
[TBL] [Abstract][Full Text] [Related]
30. Retroviral transduction of acute myeloid leukaemia-derived dendritic cells with OX40 ligand augments their antigen presenting activity.
Yanagita S; Hori T; Matsubara Y; Ishikawa T; Uchiyama T
Br J Haematol; 2004 Feb; 124(4):454-62. PubMed ID: 14984494
[TBL] [Abstract][Full Text] [Related]
31. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
[TBL] [Abstract][Full Text] [Related]
32. Influences of interferon-alpha on expression of Th cytokines and CCR7 in dendritic cells from patients with chronic myeloid leukemia in vitro.
Zhao WL; Chai YH; He HL; Wei XC; Wang T; Xing PN; Li MS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):401-5. PubMed ID: 18426674
[TBL] [Abstract][Full Text] [Related]
33. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
[TBL] [Abstract][Full Text] [Related]
34. Granulocyte/macrophage-colony-stimulating-factor plus interleukin-2 plus interferon alpha in the treatment of metastatic renal cell carcinoma: a pilot study.
Westermann J; Reich G; Kopp J; Haus U; Dörken B; Pezzutto A
Cancer Immunol Immunother; 2001 Jan; 49(11):613-20. PubMed ID: 11225992
[TBL] [Abstract][Full Text] [Related]
35. Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in IL-2 followed by IL-2, GM-CSF, and IFN-alpha administration.
Hájek R; Zácková D; Büchler T; Penka M; Krahulcová E; Korístek Z; Vinklárková J; Adler J; Janovská E; Indrák K; Faber E; Doubek M; Klabusay M; Oltová A; Kuglík P; Bourková L; Dusek L; Mareschová I; Mayer J; Vorlícek J
Med Oncol; 2003; 20(1):69-76. PubMed ID: 12665687
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte-macrophage colony-stimulating factor induces the differentiation of murine erythroleukaemia cells into dendritic cells.
Cao X; Zhao Y; Yu Y; Wang Y; Zhang M; Zhang W; Wang J
Immunology; 1998 Sep; 95(1):141-7. PubMed ID: 9767469
[TBL] [Abstract][Full Text] [Related]
37. [Calcium ionophore induces the differentiation of chronic myeloid leukemia cells into dendritic cells].
Zhou HR; Chen JM; Chen ZZ; Wu SW; Guo JR; Huang YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1192-7. PubMed ID: 19840448
[TBL] [Abstract][Full Text] [Related]
38. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha.
Della Bella S; Nicola S; Riva A; Biasin M; Clerici M; Villa ML
J Leukoc Biol; 2004 Jan; 75(1):106-16. PubMed ID: 14525963
[TBL] [Abstract][Full Text] [Related]
39. Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
Westermann J; Kopp J; van Lessen A; Hecker AC; Baskaynak G; le Coutre P; Döhner K; Döhner H; Dörken B; Pezzutto A
Br J Haematol; 2007 May; 137(4):297-306. PubMed ID: 17408402
[TBL] [Abstract][Full Text] [Related]
40. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]